title: Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolism.
abstract: The effects of 100 mg of intranasal cocaine in acute alcohol intoxication (0.8 g/kg) were evaluated in eight experienced and nondependent healthy volunteers in a double-blind double-dummy, controlled, randomized, crossover clinical study. The combination of alcohol and cocaine produced greater increases in HR, rate-pressure product and pleasurable-related subjective effects (euphoria, well-being) compared with the effects of cocaine. The drug combination reduced the alcohol-induced sedation, but feelings of drunkenness were not significantly counteracted. Cardiovascular changes induced by the combination condition caused an increase in myocardial oxygen consumption that may be related to an increased risk of cardiovascular toxicity. The augmented subjective euphoria may explain why the drug combination is more likely to be abused than is cocaine or alcohol alone. Plasma cortisol concentrations were significantly higher after concomitant alcohol and cocaine use than with cocaine alone. The administration of cocaine did not alter alcohol-induced hyperprolactinemia. Although cocaine produced a slight decrease in plasma concentrations of prolactin when administered alone, it did not antagonize the effects of alcohol on prolactin secretion when alcohol and cocaine were given simultaneously. The combination increased cocaine and norcocaine plasma concentrations, and induced the synthesis of cocaethylene and norcocaethylene. The enhancement of cocaine effects in the drug combination may be due to initially increased cocaine plasma levels followed by the additive effect of cocaethylene, although a pharmacodynamic interaction could not be excluded.
authors.affiliation: Department of Pharmacology and Toxicology, Institut Municipal d'Investigació Mèdica, Autonomous University of Barcelona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Farré
authors.forename: R
authors.initials: R
authors.lastname: de la Torre
authors.forename: M L
authors.initials: ML
authors.lastname: González
authors.forename: M T
authors.initials: MT
authors.lastname: Terán
authors.forename: P N
authors.initials: PN
authors.lastname: Roset
authors.forename: E
authors.initials: E
authors.lastname: Menoyo
authors.forename: J
authors.initials: J
authors.lastname: Camí
mesh_terms: D000324:Adrenocorticotropic Hormone / Q000097:blood; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D003042:Cocaine / Q000031:analogs & derivatives* / Q000378:metabolism / Q000493:pharmacokinetics / Q000494:pharmacology*; D004298:Dopamine / Q000378:metabolism; D004357:Drug Synergism; D000431:Ethanol / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D011388:Prolactin / Q000097:blood
chemical_list: D000431:Ethanol; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; C066444:cocaethylene; D003042:Cocaine; D004298:Dopamine; D006854:Hydrocortisone